The study population, which differs in age, sex, obesity or overweight, presence of dyslipidemia, T2DM/prediabetes, physical activity or other comorbidities, may have a significant impact on irisin concentration. The gene discussed is FNDC5; the disease is type 2 diabetes mellitus.